Zhao JJ - Search Results

1

Effectiveness of Immune Checkpoint Inhibitors in Patients With Advanced Esophageal Squamous Cell Carcinoma: A Meta-analysis Including Low PD-L1 Subgroups.

Yap DWT, Leone AG, Wong NZH, Zhao JJ, Tey JCS, Sundar R, Pietrantonio F. Yap DWT, et al. Among authors: zhao jj. JAMA Oncol. 2023 Feb 1;9(2):215-224. doi: 10.1001/jamaoncol.2022.5816. JAMA Oncol. 2023. PMID: 36480211 Free PMC article.

2

Low-Dose Nivolumab in Renal Cell Carcinoma: A Real-World Experience.

Zhao JJ, Kumarakulasinghe NB, Muthu V, Lee M, Walsh R, Low JL, Choo J, Tan HL, Chong WQ, Ang Y, Chan G, Yong WP, Huang Y, Ngoi N, Wong A. Zhao JJ, et al. Oncology. 2021;99(3):192-202. doi: 10.1159/000512000. Epub 2021 Jan 13. Oncology. 2021. PMID: 33440374

3

Low Programmed Death-Ligand 1-Expressing Subgroup Outcomes of First-Line Immune Checkpoint Inhibitors in Gastric or Esophageal Adenocarcinoma.

Zhao JJ, Yap DWT, Chan YH, Tan BKJ, Teo CB, Syn NL, Smyth EC, Soon YY, Sundar R. Zhao JJ, et al. J Clin Oncol. 2022 Feb 1;40(4):392-402. doi: 10.1200/JCO.21.01862. Epub 2021 Dec 3. J Clin Oncol. 2022. PMID: 34860570 Review.

4

KMSubtraction: reconstruction of unreported subgroup survival data utilizing published Kaplan-Meier survival curves.

Zhao JJ, Syn NL, Tan BKJ, Yap DWT, Teo CB, Chan YH, Sundar R. Zhao JJ, et al. BMC Med Res Methodol. 2022 Apr 3;22(1):93. doi: 10.1186/s12874-022-01567-z. BMC Med Res Methodol. 2022. PMID: 35369867 Free PMC article.

5

First-Line Systemic Therapies for Advanced Hepatocellular Carcinoma: A Systematic Review and Patient-Level Network Meta-Analysis.

Fong KY, Zhao JJ, Sultana R, Lee JJX, Lee SY, Chan SL, Yau T, Tai DWM, Sundar R, Too CW. Fong KY, et al. Among authors: zhao jj. Liver Cancer. 2022 Aug 23;12(1):7-18. doi: 10.1159/000526639. eCollection 2023 Feb. Liver Cancer. 2022. PMID: 36872922 Free PMC article.

6

Evidence on Effectiveness of Immune Checkpoint Inhibitors in Patients With Advanced Esophageal Squamous Cell Carcinoma-Reply.

Zhao JJ, Pietrantonio F, Sundar R. Zhao JJ, et al. JAMA Oncol. 2023 Jul 1;9(7):1005-1006. doi: 10.1001/jamaoncol.2023.0975. JAMA Oncol. 2023. PMID: 37166787 No abstract available.

7

Factors Predictive of Primary Resistance to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer.

Huang Y, Zhao JJ, Soon YY, Kee A, Tay SH, Aminkeng F, Ang Y, Wong ASC, Bharwani LD, Goh BC, Soo RA. Huang Y, et al. Among authors: zhao jj. Cancers (Basel). 2023 May 12;15(10):2733. doi: 10.3390/cancers15102733. Cancers (Basel). 2023. PMID: 37345072 Free PMC article.

8

Indirect Treatment Comparison of First-Line CDK4/6-Inhibitors in Post-Menopausal Patients with HR+/HER2- Metastatic Breast Cancer.

Zhao JJ, Fong KY, Chan YH, Tey J, Dawood S, Lee SC, Finn RS, Sundar R, Lim JSJ. Zhao JJ, et al. Cancers (Basel). 2023 Sep 14;15(18):4558. doi: 10.3390/cancers15184558. Cancers (Basel). 2023. PMID: 37760527 Free PMC article.

9

Atypical Response Patterns in Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors-Navigating the Radiologic Potpourri.

Wong A, Vellayappan B, Cheng L, Zhao JJ, Muthu V, Asokumaran Y, Low JL, Lee M, Huang YQ, Kumarakulasinghe NB, Ngoi N, Leong CN, Chua W, Thian YL. Wong A, et al. Among authors: zhao jj. Cancers (Basel). 2021 Apr 2;13(7):1689. doi: 10.3390/cancers13071689. Cancers (Basel). 2021. PMID: 33918397 Free PMC article.

10

Intra-Arterial Therapy for Unresectable Colorectal Liver Metastases: A Meta-Analysis.

Zhao JJ, Tan E, Sultana R, Syn NL, Da Zhuang K, Leong S, Tai DWM, Too CW. Zhao JJ, et al. J Vasc Interv Radiol. 2021 Nov;32(11):1536-1545.e38. doi: 10.1016/j.jvir.2021.05.032. Epub 2021 Jun 22. J Vasc Interv Radiol. 2021. PMID: 34166803

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

975 results

Search Page